头孢替林

{{Drugbox
| verifiedrevid = 443726531
| IUPAC_name = (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)- 2-(hydroxyimino)acetyl]amino}-8-oxo-3-{[(1H-1,2,3- triazol-4-ylsulfanyl)methyl]sulfanyl}-5-thia-1- azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image = Cefmatilen.svg
| width = 280

| tradename =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration = 口服

| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

| CAS_number_Ref =
| CAS_number = 140128-74-1
| CAS_number2=154776-45-1|CAS_number2_comment=HCl · H2O
| ATC_prefix = none
| ATC_suffix =
| PubChem = 9690121
| DrugBank_Ref =
| DrugBank =
| ChEMBL = 2104438
| ChemSpiderID_Ref =
| ChemSpiderID = 4912110
| UNII_Ref =
| UNII = T750UM24H8

| C=15 | H=14 | N=8 | O=5 | S=4
| smiles = C1C(=C(N2C@HC@@HNC(=O)/C(=N\O)/C3=CSC(=N3)N)C(=O)O)SCSC4=NNN=C4
| StdInChI_Ref =
| StdInChI = 1S/C15H14N8O5S4/c16-15-18-5(2-30-15)8(21-28)11(24)19-9-12(25)23-10(14(26)27)6(3-29-13(9)23)31-4-32-7-1-17-22-20-7/h1-2,9,13,28H,3-4H2,(H2,16,18)(H,19,24)(H,26,27)(H,17,20,22)/b21-8-/t9-,13-/m1/s1
| StdInChIKey_Ref =
| StdInChIKey = UEQVTKSAEXANEZ-YCRCPZNHSA-N
}}
头孢替林（INN：Cefmatilen，开发代号：S-1090）是一种口服活性头孢菌素抗生素。它于日本研發，并于1992年首次描述。

参考资料
延伸阅读
*